These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Glioblastoma cancer stem cells--from concept to clinical application. Stopschinski BE; Beier CP; Beier D Cancer Lett; 2013 Sep; 338(1):32-40. PubMed ID: 22668828 [TBL] [Abstract][Full Text] [Related]
6. Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57. Zhu X; Prasad S; Gaedicke S; Hettich M; Firat E; Niedermann G Oncotarget; 2015 Jan; 6(1):171-84. PubMed ID: 25426558 [TBL] [Abstract][Full Text] [Related]
7. CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme. Choy W; Nagasawa DT; Trang A; Thill K; Spasic M; Yang I Neurosurg Clin N Am; 2012 Jul; 23(3):391-405. PubMed ID: 22748652 [TBL] [Abstract][Full Text] [Related]
8. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Fan X; Khaki L; Zhu TS; Soules ME; Talsma CE; Gul N; Koh C; Zhang J; Li YM; Maciaczyk J; Nikkhah G; Dimeco F; Piccirillo S; Vescovi AL; Eberhart CG Stem Cells; 2010 Jan; 28(1):5-16. PubMed ID: 19904829 [TBL] [Abstract][Full Text] [Related]
9. CD133 is essential for glioblastoma stem cell maintenance. Brescia P; Ortensi B; Fornasari L; Levi D; Broggi G; Pelicci G Stem Cells; 2013 May; 31(5):857-69. PubMed ID: 23307586 [TBL] [Abstract][Full Text] [Related]
10. Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. Pistollato F; Abbadi S; Rampazzo E; Persano L; Della Puppa A; Frasson C; Sarto E; Scienza R; D'avella D; Basso G Stem Cells; 2010 May; 28(5):851-62. PubMed ID: 20309962 [TBL] [Abstract][Full Text] [Related]
11. Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes. Jin F; Zhao L; Zhao HY; Guo SG; Feng J; Jiang XB; Zhang SL; Wei YJ; Fu R; Zhao JS Neuroscience; 2008 Jun; 154(2):541-50. PubMed ID: 18462887 [TBL] [Abstract][Full Text] [Related]
12. Neural stem cells and glioblastoma. Rispoli R; Conti C; Celli P; Caroli E; Carletti S Neuroradiol J; 2014 Apr; 27(2):169-74. PubMed ID: 24750704 [TBL] [Abstract][Full Text] [Related]
13. ADAM17 regulates self-renewal and differentiation of U87 glioblastoma stem cells. Chen X; Chen L; Zhang R; Yi Y; Ma Y; Yan K; Jiang X; Wang X Neurosci Lett; 2013 Mar; 537():44-9. PubMed ID: 23356982 [TBL] [Abstract][Full Text] [Related]
14. Characterization of glioma stem-like cells from human glioblastomas. Yamamuro S; Okamoto Y; Sano E; Ochiai Y; Ogino A; Ohta T; Hara H; Ueda T; Nakayama T; Yoshino A; Katayama Y Int J Oncol; 2015 Jul; 47(1):91-6. PubMed ID: 25955568 [TBL] [Abstract][Full Text] [Related]
15. Brain tumor stem cells from an adenoid glioblastoma multiforme. Oka N; Soeda A; Noda S; Iwama T Neurol Med Chir (Tokyo); 2009 Apr; 49(4):146-50; discussion 150-1. PubMed ID: 19398857 [TBL] [Abstract][Full Text] [Related]
16. Glioblastoma stem-like cells give rise to tumour endothelium. Wang R; Chadalavada K; Wilshire J; Kowalik U; Hovinga KE; Geber A; Fligelman B; Leversha M; Brennan C; Tabar V Nature; 2010 Dec; 468(7325):829-33. PubMed ID: 21102433 [TBL] [Abstract][Full Text] [Related]
17. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling. Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372 [TBL] [Abstract][Full Text] [Related]
18. Glioblastoma and stem cells. Altaner C Neoplasma; 2008; 55(5):369-74. PubMed ID: 18665745 [TBL] [Abstract][Full Text] [Related]